An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma
Standard
An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma. / Albert, Thomas K; Interlandi, Marta; Sill, Martin; Graf, Monika; Moreno, Natalia; Menck, Kerstin; Rohlmann, Astrid; Melcher, Viktoria; Korbanka, Sonja; Meyer Zu Hörste, Gerd; Lautwein, Tobias; Frühwald, Michael C; Krebs, Christian F; Holdhof, Dörthe; Schoof, Melanie; Bleckmann, Annalen; Missler, Markus; Dugas, Martin; Schüller, Ulrich; Jäger, Natalie; Pfister, Stefan M; Kerl, Kornelius.
in: NEURO-ONCOLOGY, Jahrgang 23, Nr. 4, 12.04.2021, S. 586-598.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma
AU - Albert, Thomas K
AU - Interlandi, Marta
AU - Sill, Martin
AU - Graf, Monika
AU - Moreno, Natalia
AU - Menck, Kerstin
AU - Rohlmann, Astrid
AU - Melcher, Viktoria
AU - Korbanka, Sonja
AU - Meyer Zu Hörste, Gerd
AU - Lautwein, Tobias
AU - Frühwald, Michael C
AU - Krebs, Christian F
AU - Holdhof, Dörthe
AU - Schoof, Melanie
AU - Bleckmann, Annalen
AU - Missler, Markus
AU - Dugas, Martin
AU - Schüller, Ulrich
AU - Jäger, Natalie
AU - Pfister, Stefan M
AU - Kerl, Kornelius
N1 - © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
PY - 2021/4/12
Y1 - 2021/4/12
N2 - BACKGROUND: Medulloblastoma (MB) is a malignant brain tumor in childhood. It comprises 4 subgroups with different clinical behaviors. The aim of this study was to characterize the transcriptomic landscape of MB, both at the level of individual tumors as well as in large patient cohorts.METHODS: We used a combination of single-cell transcriptomics, cell culture models and biophysical methods such as nanoparticle tracking analysis and electron microscopy to investigate intercellular communication in the MB tumor niche.RESULTS: Tumor cells of the sonic hedgehog (SHH)-MB subgroup show a differentiation blockade. These cells undergo extensive metabolic reprogramming. The gene expression profiles of individual tumor cells show a partial convergence with those of tumor-associated glial and immune cells. One possible cause is the transfer of extracellular vesicles (EVs) between cells in the tumor niche. We were able to detect EVs in co-culture models of MB tumor cells and oligodendrocytes. We also identified a gene expression signature, EVS, which shows overlap with the proteome profile of large oncosomes from prostate cancer cells. This signature is also present in MB patient samples. A high EVS expression is one common characteristic of tumors that occur in high-risk patients from different MB subgroups or subtypes.CONCLUSIONS: With EVS, our study uncovered a novel gene expression signature that has a high prognostic significance across MB subgroups.
AB - BACKGROUND: Medulloblastoma (MB) is a malignant brain tumor in childhood. It comprises 4 subgroups with different clinical behaviors. The aim of this study was to characterize the transcriptomic landscape of MB, both at the level of individual tumors as well as in large patient cohorts.METHODS: We used a combination of single-cell transcriptomics, cell culture models and biophysical methods such as nanoparticle tracking analysis and electron microscopy to investigate intercellular communication in the MB tumor niche.RESULTS: Tumor cells of the sonic hedgehog (SHH)-MB subgroup show a differentiation blockade. These cells undergo extensive metabolic reprogramming. The gene expression profiles of individual tumor cells show a partial convergence with those of tumor-associated glial and immune cells. One possible cause is the transfer of extracellular vesicles (EVs) between cells in the tumor niche. We were able to detect EVs in co-culture models of MB tumor cells and oligodendrocytes. We also identified a gene expression signature, EVS, which shows overlap with the proteome profile of large oncosomes from prostate cancer cells. This signature is also present in MB patient samples. A high EVS expression is one common characteristic of tumors that occur in high-risk patients from different MB subgroups or subtypes.CONCLUSIONS: With EVS, our study uncovered a novel gene expression signature that has a high prognostic significance across MB subgroups.
U2 - 10.1093/neuonc/noaa254
DO - 10.1093/neuonc/noaa254
M3 - SCORING: Journal article
C2 - 33175161
VL - 23
SP - 586
EP - 598
JO - NEURO-ONCOLOGY
JF - NEURO-ONCOLOGY
SN - 1522-8517
IS - 4
ER -
